Zacks.com on MSN1h
Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded DealThis week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...
Zacks.com on MSN23h
NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to BuyNovo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
Developers are now working on new versions and improving the results of artificial intelligence.
Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation ...
News Medical on MSN3h
Health care AI, intended to save money, turns out to require a lot of expensive humansPreparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
In November 2023, the estates of two now-deceased policyholders sued the US health insurer, United Healthcare, for deploying ...
Pronto Translations today announced a new survey of businesses that examined preferences for translation services when ...
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback